Cell Surface Bio was spun out of Integral Molecular, a 23-year-old University City biotechnology company that uses its expertise in targeted biology antibody discovery, virology, and protein engineering to help drug developers advance potential new therapies for difficult to treat diseases.
Cell Surface Bio’s operations will initially be within Integral Molecular, a 100-employee company which is in process of adding 16,000 square feet to its 32,000-square-foot headquarters in uCity Square at 25 N. 38th St.